Patients Who Had Severe COVID-19 May Be Best Plasma Donors: Study
TUESDAY, Oct. 27, 2020 -- Factors such as sex, age and severity of the disease may help identify COVID-19 survivors who have high levels of antibodies that can protect against the disease, a new study suggests.
"These were significant patient characteristics that not only predicted the amount of antibody but the quality of that antibody," said lead author Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health in Baltimore.
Specifically, older men who have recovered after a hospital stay for COVID-19 may be good candidates for donating plasma for treating other infected patients, the study suggests.
Plasma trials are continuing, but doctors are unsure how to select COVID-19 survivors who are most likely to have strong antibody responses.
For the study, researchers tested the blood of 126 COVID-19 survivors and found many differences in their antibody levels and their antibodies' ability to neutralize SARS-CoV-2. Factors linked with stronger antibody responses included being sick enough to be hospitalized, being older and being male.
"We know that the magnitude of antibody responses correlates with disease severity in other infectious diseases, such as active tuberculosis," Klein said in a Hopkins news release.
The findings were recently published in the Journal of Clinical Investigation.
© 2020 HealthDay. All rights reserved.
Posted: October 2020
Further Support and Information on COVID-19
Read this next
TUESDAY, Nov. 24, 2020 -- People infected with the new coronavirus are most contagious in the first week after they develop symptoms, which shows the importance of identifying and...
TUESDAY, Nov. 24, 2020 -- The number of confirmed COVID-19 cases in the United States is likely to nearly double before President-elect Joe Biden's inauguration, researchers...
TUESDAY, Nov. 24, 2020 – At least thee new COVID-19 vaccine candidates are already in the pipeline, will a roll-out expected early in the new year. But on Monday, experts...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.